Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability

Jill Clayton-Smith (1) , Rebecca Bromley (1) , John Dean , Hubert Journel , Sylvie Odent (2) , Amanda Wood , Janet Williams , Verna Cuthbert , Latha Hackett , Neelo Aslam , Heli Malm (3) , Gregory James , Lena Westbom , Ruth Day , Edmund Ladusans , Adam Jackson , Iain Bruce , Robert Walker , Sangeet Sidhu , Catrina Dyer , Jane Ashworth , Daniel Hindley , Gemma Arca Diaz , Myfanwy Rawson , Peter Turnpenny

1 MFT - Manchester University NHS Foundation Trust
2 IGDR - Institut de Génétique et Développement de Rennes
3 Helsingin yliopisto = Helsingfors universitet = University of Helsinki

Keywords: Fetal valproate syndrome; Expert consensus; Management; Guideline; Teratogen; Antiepileptic drug

Domains: Life Sciences [q-bio]

Jill Clayton-Smith, Rebecca Bromley, John Dean, Hubert Journel, Sylvie Odent, et al.. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability. Orphanet Journal of Rare Diseases, 2019, 14 (1), pp.180. ⟨10.1186/s13023-019-1064-y⟩. ⟨hal-02277996⟩